Ledger.Open graph →
SEC Form D · Amendment · filed February 19, 2025

Adze Biotechnology Inc

Offering
$15.0M
Sold
$6.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Coral Gables, FL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Gloria J. Olivier · Rochester, MNDirectorKenneth J. Templin · Oak Park, ILExecBrendan P. Kenny · Edmonton, Alberta, CanadaDirectorG. P. Sage, Ii · Kalamazoo, MIDirectorSidney Hopps · Miami, FLExec · DirectorGabriel P. Raviv · Glenview, ILDirectorStewart Kohl · CLEVELAND, OHDirectorJonathan S. Beach · The Woodlands, TXDirectorTerrence A. Avella · New York, NYExecSidney Hopps · Miami, FLExec · DirectorBela Szigethy · NEW YORK, NYDirectorDavid Reiss · NEW YORK, NYDirectorBernard Lawrence · St Peter Port, Y7ExecSateeta N. Jeewoolall Jessoo · Trianon, O4DirectorSPV Solutions Management I LLC · Salt Lake City, UTDirectorRichard Robb · New York, NYDirectorRoger Renaud · Montreal, Quebec, CanadaDirectorSteve Nawrocki · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗